Predictive value of complement activation fragments C3a and sC5b‐9 for development of severe disease in patients with acute pancreatitis

MLA

Beat Gloor, et al. “Predictive Value of Complement Activation Fragments C3a and SC5b‐9 for Development of Severe Disease in Patients with Acute Pancreatitis.” Scandinavian Journal of Gastroenterology, vol. 38, Jan. 2003, pp. 1078–82. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b0392f1d4dea8986aec31b6d28e1841&authtype=sso&custid=ns315887.

APA

Beat Gloor, Christoph A. Müller, Waldemar Uhl, Philip F. Stahel, M W Büchler, & Oliver Schmidt. (2003). Predictive value of complement activation fragments C3a and sC5b‐9 for development of severe disease in patients with acute pancreatitis. Scandinavian Journal of Gastroenterology, 38, 1078–1082.

Chicago

Beat Gloor, Christoph A. Müller, Waldemar Uhl, Philip F. Stahel, M W Büchler, and Oliver Schmidt. 2003. “Predictive Value of Complement Activation Fragments C3a and SC5b‐9 for Development of Severe Disease in Patients with Acute Pancreatitis.” Scandinavian Journal of Gastroenterology 38 (January): 1078–82. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b0392f1d4dea8986aec31b6d28e1841&authtype=sso&custid=ns315887.